We finally tested whether Tmem219 genetic deletion in the ISC-Tmem219–/– mice was effective in a treatment model, in which 2.5% DSS was orally administered for 5 days and Tmem219 genetic deletion was induced after the onset of colitis (Supplemental Figure 9A). The gene discussed is TMEM219; the disease is colitis.